AKT1 and skin squamous cell carcinoma: Here, we investigated the sensitivity of some of these cells to selective class I PI3Ks inhibitors to identify the main isoform(s) involved in regulation of their growth, viability and Akt activation, and to start evaluating the potential therapeutic value of these inhibitors in cSCC.